Discovery of potent colony-stimulating factor 1 receptor inhibitors by replacement of hinge-binder moieties
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, J.W. | - |
dc.contributor.author | Park, J. | - |
dc.contributor.author | Kim, J. | - |
dc.contributor.author | Kim, J. | - |
dc.contributor.author | Choi, C. | - |
dc.contributor.author | Min, K.H. | - |
dc.date.accessioned | 2021-07-15T04:40:21Z | - |
dc.date.available | 2021-07-15T04:40:21Z | - |
dc.date.issued | 2021-04-15 | - |
dc.identifier.issn | 0223-5234 | - |
dc.identifier.issn | 1768-3254 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/47537 | - |
dc.description.abstract | Tumor-associated macrophages (TAMs) are predominantly associated with tumor growth. Colony-stimulating factor 1 receptor (CSF1R) acts as a key regulator of TAM survival and differentiation and is a molecular target for cancer therapies. Herein, novel CSF1R inhibitors were identified through a replacement strategy for the hinge-binding moiety. The introduction of imidazo[1,2-a]pyridine (49) or pyrazolo[1,5-a]pyridine (50) as hinge binders led to 87% and 82% inhibition at 10 nM for CSF1R in the enzymatic assay, with IC50 values of 25 nM and 27 nM in MNFS60 cells, respectively. These derivatives significantly inhibited CSF1R phosphorylation in cells. Our approach could be utilized as a strategy to discover novel kinase inhibitors. © 2021 Elsevier Masson SAS | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Elsevier Masson s.r.l. | - |
dc.title | Discovery of potent colony-stimulating factor 1 receptor inhibitors by replacement of hinge-binder moieties | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.ejmech.2021.113298 | - |
dc.identifier.bibliographicCitation | European Journal of Medicinal Chemistry, v.216 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000637742700014 | - |
dc.identifier.scopusid | 2-s2.0-85102071913 | - |
dc.citation.title | European Journal of Medicinal Chemistry | - |
dc.citation.volume | 216 | - |
dc.type.docType | Article | - |
dc.publisher.location | 프랑스 | - |
dc.subject.keywordAuthor | CSF1R | - |
dc.subject.keywordAuthor | Hinge binder | - |
dc.subject.keywordAuthor | Kinase inhibitor | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.